Stocks
Johnson & JohnsonJNJ
NYSEHealthcarePharmaceuticals$241.52-0.21%
A diversified healthcare manufacturer focused on prescription pharmaceuticals and medical technology products used in areas such as oncology, immunology, surgery, and orthopedics. The company generates the majority of revenue from its drug portfolio while maintaining a large global medtech business ...
Market Cap: $582.0B52W Range: $141.50 – $251.71
Congressional Interest in Johnson & Johnson (JNJ)
24 members of Congress have disclosed 50 trades in Johnson & Johnson (JNJ), a Healthcare company. The buy/sell breakdown shows 21 purchases versus 29 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
24
Buys
21
Sells
29
Who in Congress Is Trading JNJ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-08-04 | MIKE KELLY | buy | $1K – $15K |
| 2016-07-28 | BOB GIBBS | buy | $1K – $15K |